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Dementia developed in a patient with widespread neu-
rologic manifestations; she died within 5 months.
Pathologic findings showed granulomatous inflammation
with caseation necrosis, foreign body–type giant cells, and
proliferative endarteritis with vascular occlusions. Broad-
range polymerase chain reaction identified Mycobacterium
neoaurum as the possible pathogen. Central nervous sys-
tem infection by M. neoaurum may result in rapidly progres-
sive dementia.
A
few dementing illnesses are characterized by rapid
cognitive decline and early emergence of neurologic
signs. Causes include malignancy, vascular disorders,
autoimmune disorders, and infections. We describe a
patient in whom dementia associated with cerebellar,
pyramidal, extrapyramidal, and bulbar manifestations
developed; the patient died within 5 months. Postmortem
examination showed chronic granulomatous meningitis
and arteritis. Broadband polymerase chain reaction (PCR)
identified the presence of DNA from Mycobacterium
neoaurum.
The Case
A 63-year-old woman was assessed for rapid function-
al decline over 2 months, with cognitive impairment, mul-
tiple falls, incontinence, and dependence for most basic
daily activities. She could ambulate no further than a few
meters despite assistance. Medical history included stroke
10 months previously with mild residual left-sided weak-
ness, depression, rheumatoid arthritis, and hypertension.
She smoked heavily, did not abuse alcohol or injection
drugs, and had never received blood products. Medications
included prednisone 5 mg daily, paroxetine, amlodipine,
clopidogrel, estrogen, calcium, vitamin D, bromazepam,
and acetaminophen. She was white and had spent all her
life within the Great Lakes area of southern Ontario. She
had once worked in a plant manufacturing leather compo-
nents for automobiles, and her husband worked briefly as
a meat packer. She had no family history of neurologic ill-
ness. She did not consume raw meat and had no contact
with livestock but used sheep manure in her garden.
Cognitive testing showed impaired abstract thinking,
memory, and attention but no affective or psychotic distur-
bance. She was afebrile with no nuchal rigidity. Speech
production was reduced, aprosodic, and dysarthric. Cranial
nerves were otherwise unremarkable. She exhibited
hypomimia, limb rigidity with intermittent cogwheeling,
and left arm dysmetria. No tremor or startle myoclonus
was noted. Power was moderately reduced in all limbs.
Reflexes were brisk with bilateral spontaneous ankle
clonus of both ankles. Bilateral plantar responses were
extensor. She could not walk unaided.
The patient was referred to a consultant and hospital-
ized. Complete blood count, blood urea nitrogen, creati-
nine, electrolytes, calcium, alkaline phosphatase, bilirubin,
thyroid-stimulating hormone, and serum B12 were normal.
Serum albumin was 28 g/L(normal 33–48 g/L), serum glu-
tamic oxaloacetic transaminase 54 U/L(normal 5–40 U/L),
serum glutamic pyruvate transaminase 58 U/L (normal
5–40 U/L), and erythrocyte sedimentation rate 74 mm/h.
Serum antinuclear antibodies, extractible nuclear antibod-
ies, antineutrophil cytoplasmic antibodies, Venereal
Disease Research Laboratory test, and complement levels
were unremarkable. Serologic tests for hepatitis B and C
and enzyme-linked immunosorbent assay for HIV were
negative. Electroencephalograph (EEG) demonstrated
intermittent irregular slow delta waves in the right frontal
and left temporal regions but no biphasic or triphasic
waves. Magnetic resonance scan of the brain showed mul-
tiple areas of remote and recent infarction involving right
frontal cortical and subcortical regions, pons and cerebel-
lum, and right parasagittal frontal cortex. A diagnosis of
recurrent strokes was made, but she continued to decline
after discharge to a rehabilitation hospital. She became
mute, immobile, and in need of complete assistance. She
freely aspirated and was hypoxic. A lumbar puncture
obtained shortly before her death showed cerebrospinal
fluid (CSF) glucose of 4.8 mmol/L (normal 2.5–4.4
mmol/L), total protein of 0.33 g/L (0.15–0.60 g/L), and 8
x 106 lymphocytes/L with no malignant cells. Bacterial,
mycobacterial, and fungal stains and cultures and viral cul-
tures were negative. Protein 14-3-3 (Centre for Research in
Neurodegenerative Disease at the University of Toronto)
was present in the CSF.
The brain weighed 1,530 g. The circle of Willis was
normal with no atheroma or occlusions. External examina-
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ties and multiple bilateral infarcts affecting the cortices,
pons, thalamus, middle temporal gyrus, and putamen.
Histologically, some infarcts were bland while others were
associated with a thick exudate characterized by granulo-
matous inflammation with caseation necrosis and foreign
body–type giant cells (Figure 1). Numerous vascular
occlusions with no atheroma were noted (Figure 2). Apro-
liferative endarteritis was observed. In some areas, the
process appeared resolved with extensive leptomeningeal
fibrosis. Ziehl-Nielsen and auramine rhodamine stains
failed to demonstrate mycobacteria. Gram stains, fungus
stains, and prion protein immunostains (3H4, Prionics,
Zurich, Switzerland) were negative. A moderate degree of
diffuse arteriolosclerosis was observed. An occluded
Charcot-Bouchard aneurysm was identified in the right
temporal cortex. 
Broad-range PCR identification was performed on
frozen brain tissue by using the modified method of Heritz
et al. (1). PCR (PerkinElmer, Foster City, CA) and lysis
buffers were pretreated with 8-methoxypsoralen at a final
concentration of 25 µg/mLand exposed to long-wave (360
nm) UV light for 15 min to destroy preexisting DNA con-
taminants. Tissue samples (approximately 2 mm3) were
lysed in 50 µL 1x PCR buffer containing 1% polyoxyeth-
ylene 10 lauryl ether and 200 µg/mL proteinase K at 56°C
overnight. Lysate, in 1- and 5-µL aliquots, was used as
template for PCR amplification with universal primers for
bacterial 16S rDNA (515FPL and 13B [2]). PCR mixture
without lysate was used as a negative control, and a cloned
16S rDNA amplification product was used as a positive
control (20 ng DNA). The PCR protocol involved a 3-min
hot start at 95°C, followed by addition of primers at 50
pmol per 50-µL mixture. Thirty cycles of PCR were per-
formed (94°C, 45s; 55°C, 45s; 72°C, 1 min) followed by a
final extension step at 72°C for 10 min, and the amplifica-
tion products were stored at 4°C. The PCR products were
separated on a 1.5% agarose gel and visualized on a UV
transilluminator after being stained with ethidium bromide
(0.5 g/mL) for 15 min at room temperature. Amplification
products were cloned into the plasmid vector
pCR2.1TOPO (Invitrogen, Burlington, Ontario). Cloned
products were fingerprinted by endonuclease digestion
with TaqI or RsaI, and unique clones were sequenced by
using dye terminator methods (ABI PRISM BigDye
Terminator Cycle Sequencing Kit, Applied Biosystems,
Foster City, CA). The resulting DNAsequences were iden-
tified by comparison with the nonredundant database at the
National Center for Biotechnology Information (3) and
showed a match of 577 of 581 nt (99%) to M. neoaurum
(GenBank accession no. AF268445).
Conclusions
M. neoaurum, first described in 1972, belongs to the M.
parafortuitum complex of the genus Mycobacterium (4).
M. neoaurum is a rapidly growing scotochromogen that is
found in soil. Eight cases of human infection from M.
neoaurum have been described in the English-language lit-
erature (5–11). Six of these cases were associated with
central venous catheters, one was associated with intra-
venous drug use, and another involved urinary isolation of
M. neoaurum during an investigation of a catheter-associ-
ated urinary tract infection. None of these cases was fatal.
CNS infection has not been previously described.
Several features of this case suggest that infection
caused by M. neoaurum was responsible. First, the patient
declined rapidly, which is unusual in common dementias.
Second, a mild CSF lymphocytic pleocytosis is consistent
with an infectious or inflammatory CNS disorder, though
rare occurrences have been reported in pathologically   con-
firmed Creutzfeldt-Jakob Disease (CJD) (12). Third, histo-
logic examination demonstrated a caseating granulomatous
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Figure 1. Meningeal infiltrate with caseation necrosis surrounded
by giant cells. A nearby vessel is surrounded by a mononuclear
cell infiltrate (occipital lobe, x250, stained with hematoxylin and
eosin–Luxol-fast blue).
Figure 2. Proliferative endarteritis. The artery is stenotic and par-
tially occluded by fibrous tissue. The residual lumen is almost com-
pletely occupied by recent thrombus (frontal lobe, x160, stained
with hematoxylin and eosin–Luxol-fast blue).process with accompanying endarteritis, consistent with
mycobacterial infection. M. neoaurum is relatively difficult
to culture; therefore, inability to cultivate the organism or
visualize it on Ziehl-Nielsen and auramine rhodamine
stains is not unexpected.
The patient had no known risk for parenteral exposure
to bloodborne pathogens and was not apparently immuno-
compromised. Although the epidemiology of her case sug-
gests mycobacterial infection through direct exposure, the
mode of acquisition is speculative. 
The patient was diagnosed with CJD. In patients with
rapidly progressive dementia, probable CJD may be diag-
nosed if myoclonus or typical EEG tracings are present,
according to Brown et al. (13). Possible CJD is diagnosed
when rapidly progressive dementia is associated with a
movement disorder or periodic EEG activity. Masters pro-
posed that probable CJD may be diagnosed in patients with
rapidly progressive dementia, biphasic or triphasic waves
on EEG, and at least two of myoclonus, visual or cerebel-
lar symptoms, pyramidal or extrapyramidal signs, and aki-
netic mutism (14). Possible CJD is diagnosed when typical
EEG findings are absent. Recent efforts to improve diag-
nostic accuracy for CJD have focused on measuring CSF
protein 14-3-3. Thought to reflect neuronal injury, report-
ed sensitivities and specificities of CSF protein 14-3-3 for
CJD in patients with rapidly progressive dementia are
84%–96% and 87%–100%, respectively (15–21). The
Masters’ criteria have been revised to reclassify possible
CJD as probable if CSF protein 14-3-3 is present (18). In
the case described, revised Masters’ criteria for probable
CJD and Brown criteria for possible CJD were met. The
false-positive rate of CSF protein 14-3-3 for CJD can be as
high as 12%, however, with other causes including vascu-
lar disorders, infectious encephalitis, anoxia, malignancy,
and even Alzheimer’s, Lewy body, and frontotemporal
dementias (15,17–21). In this patient, the presence of CSF
protein 14-3-3 likely reflected ischemic injury mediated by
the proliferative arteritis.
In summary, we have described a case of rapidly pro-
gressive dementia with prominent neurologic features
attributable to chronic granulomatous meningitis and
arteritis. Despite negative stains and cultures, the identifi-
cation of DNA from M. neoaurum suggests that this case
may represent the first reported CNS infection from this
organism, as well as the first documented fatality. The
absence of any clear mode of infection or predisposing risk
factors for developing such a devastating infection is
unusual. This case highlights the difficulties in achieving a
causative diagnosis in patients with rapidly progressive
dementia. CSF protein 14-3-3 does not entirely rule out
potentially treatable causes, and in this case an angiogram
would likely not have been able to differentiate inflamma-
tory from infectious vasculitis. More definitive diagnostic
methods are required, including a possible role for PCR
analysis of CSF samples, as well as earlier consideration of
biopsy.
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